Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL756844 | 0.97 | ALDH1A1 (0.57) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| Hydrochloric Acid SCHEMBL1937107 | 0.94 | ALDH1A1 (0.62) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| Water SCHEMBL973500 | 0.94 | ALDH1A1 (0.55) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| Fluoride Ion SCHEMBL7789157 | 0.94 | ALDH1A1 (0.55) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| Bromide SCHEMBL995842 | 0.94 | ALDH1A1 (0.55) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| SCHEMBL7641909 | 0.86 | ALDH1A1 (0.48) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| SCHEMBL7640984 | 0.86 | ALDH1A1 (0.48) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| SCHEMBL6043431 | 0.86 | ALDH1A1 (0.48) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| SCHEMBL7642773 | 0.84 | ALDH1A1 (0.46) | ALDH1A1TDP1KDM4ECALM1TSHR | |
| Iodide SCHEMBL5087561 | 0.84 | KDM4E (0.52) | ALDH1A1TDP1KDM4ETP53DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1144990-A1 | A REFERENCE ELECTRODE SOLUTION CONTAINING ORGANIC AMMONIUM AND PHOSPHONIUM SALTS FOR POTENTIOMETRIC MEASUREMENT OF pH | BAXTER INTERNATIONAL INC. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000033064-A9 | A REFERENCE ELECTRODE SOLUTION CONTAINING ORGANIC AMMONIUM AND PHOSPHONIUM SALTS FOR POTENTIOMETRIC MEASUREMENT OF pH | BAXTER INT (US) | 2001-03-29 | — | — | WO | claimed |
| WO-2000033064-A1 | A REFERENCE ELECTRODE SOLUTION CONTAINING ORGANIC AMMONIUM AND PHOSPHONIUM SALTS FOR POTENTIOMETRIC MEASUREMENT OF pH | BAXTER INTERNATIONAL INC. (US) | 2000-06-08 | — | — | WO | claimed |
| US-20080214386-A1 | Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-1434624-B1 | 2-AMINO-6-(2,4,5-SUBSTITUTED-PHENYL)-PYRIDINES FOR USE AS NITRIC OXIDE SYNTHASE INHIBITORS | PFIZER PROD INC (US) | 2006-11-02 | — | — | EP | disclosed |
| US-20050032847-A1 | 2-amino-6(2,4,5-substitued-phenyl)-pyridines | PFIZER INC. | 2005-02-10 | — | — | US | disclosed |
| US-6803470-B2 | NITRIC OXIDE SYNTHASE INHIBITORS. | PFIZER INC | 2004-10-12 | — | — | US | disclosed |
| EP-1434624-A1 | 2-AMINO-6-(2,4,5-SUBSTITUTED-PHENYL)-PYRIDINES FOR USE AS NITRIC OXIDE SYNTHASE INHIBITORS | Pfizer Products Inc. (US) | 2004-07-07 | — | — | EP | disclosed |
| US-20040077853-A1 | 2-amino-6-(2,4,5-substituted-phenyl)-pyridines | PFIZER INC. | 2004-04-22 | — | — | US | disclosed |
| US-20030087891-A1 | 2-Amino-6-(2,4,5-substituted-phenyl)-pyridines | PFIZER INC. | 2003-05-08 | — | — | US | disclosed |
| WO-2003030993-A1 | 2-AMINO-6-(2,4,5-SUBSTITUTED-PHENYL)-PYRIDINES FOR USE AS NITRIC OXIDE SYNTHASE INHIBITORS | PFIZER PRODUCTS INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| US-6221222-B1 | USE OF AMMONIUM SALTS OR PHOSPHONIUM SALTS AS REFERENCE ELECTROLYTES TO MINIMIZE THE FORMATION OF PRECIPITATES IN SOLUTIONS CONTAINING SENSITIVE COMPOUNDS DURING POTNTIOMETRIC MEASUREMENT OF PH | BAXTER INTERNATIONAL INC. | 2001-04-24 | — | — | US | disclosed |
| EP-0342064-B1 | A thermosetting resinous composition and preparation of heat resisting coating and molded product using said composition | NIPPON PAINT CO LTD (JP) | 1995-02-15 | — | — | EP | disclosed |
| US-5126423-A | Forming heat-resistant moldings of polyoxazolidones; catalyst selectivity | NIPPON PAINT CO., LTD. (JP) | 1992-06-30 | — | — | US | disclosed |
| EP-0342064-A2 | A thermosetting resinous composition and preparation of heat resisting coating and molded product using said composition | NIPPON PAINT CO., LTD. (JP) | 1989-11-15 | — | — | EP | disclosed |
| EP-0161550-B1 | PROCESS FOR PRODUCING AN ALIPHATIC ISOCYANATE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-01-20 | — | — | EP | disclosed |
| US-4587056-A | CARBONYLATION, OXIDATION, CATALYST | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1986-05-06 | — | — | US | disclosed |
| EP-0161550-A1 | Process for producing an aliphatic isocyanate | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-11-21 | — | — | EP | disclosed |
| US-4124630-A | Process for the production of chloromethyl thiocyanate | OFFERMANNS HERIBERT | 1978-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087891-A1 | 2-Amino-6-(2,4,5-substituted-phenyl)-pyridines | PNMT, HTR6, HTR2C | ALDH1A1 1506/4885TDP1 1236/4885KDM4E 193/4885 |
| US-20040077853-A1 | 2-amino-6-(2,4,5-substituted-phenyl)-pyridines | NOS3, NOS1, NOS2 | ALDH1A1 362/4885TDP1 611/4885KDM4E 544/4885 |
| US-20050032847-A1 | 2-amino-6(2,4,5-substitued-phenyl)-pyridines | PNMT, HTR6, HTR2C | ALDH1A1 1325/4885TDP1 1777/4885KDM4E 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.